Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06–2018 study)

Authors: Amari, Lyria, Tomasini, Pascale, Dantony, Emmanuelle, Rousseau-Bussac, Gaelle, Ricordel, Charles, Bigay-Game, Laurence, Arpin, Dominique, Morel, Hugues, Veillon, Remi, Justeau, Grégoire, Huchot, Eric, Fournel, Pierre, Vergnenegre, Alain, Bizeux, Acya, Subtil, Fabien, Clarisse, Bénédicte, Decroisette, Chantal, Chouaid, Christos, Greillier, Laurent, Bylicki, Olivier

Source: In Lung Cancer July 2024 193

Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018

Authors: Bylicki, Olivier, Tomasini, Pascale, Radj, Gervais, Guisier, Florian, Monnet, Isabelle, Ricordel, Charles, Bigay-Game, Laurence, Geier, Margaux, Chouaid, Christos, Daniel, Catherine, Swalduz, Aurelie, Toffart, Anne-Claire, Doubre, Helene, Peloni, Jean-Michel, Moreau, Diane, Subtil, Fabien, Grellard, Jean-Michel, Castera, Marie, Clarisse, Benedicte, Martins-Lavinas, Pedro-Henrique, Decroisette, Chantal, Greillier, Laurent

Source: European journal of cancer. 183:38-48

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190699424.0x000001&indx=1&recIds=ETOCvdc_100190699424.0x000001

PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients

Authors: Remon, Jordi, Girard, Nicolas, Novello, Silvia, de Castro, Javier, Bigay-Game, Laurence, Bernabé, Reyes, Greillier, Laurent, Mosquera, Joaquin, Cousin, Sophie, Juan, Oscar, Sampayo, Miguel, Besse, Benjamin

Source: Clinical lung cancer. 23(3):e243-e246

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165206037.0x000001&indx=1&recIds=ETOCvdc_100165206037.0x000001

Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network

Authors: Petat, Arthur, Dansin, Eric, Calcagno, Fabien, Greillier, Laurent, Pichon, Eric, Kerjouan, Mallorie, Clement-Duchene, Christelle, Mennecier, Bertrand, Westeel, Virginie, Thillays, François, Quantin, Xavier, Oulkhouir, Youssef, Thiberville, Luc, Ricordel, Charles, Thomas De Montpreville, Vincent, Chalabreysse, Lara, Hofman, Véronique, Molina, Thierry, Fournel, Pierre, Bigay Game, Laurence, Besse, Benjamin, Girard, Nicolas

Source: European journal of cancer. 162:118-127

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154776109.0x000001&indx=1&recIds=ETOCvdc_100154776109.0x000001

Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

Authors: Israel-Biet, Dominique, Pison, Christophe, Moro-Sibilot, Denis, Lantuejoul, Sylvie, Stephanov, Olivier, Juliette, Meyzenc, Mendozat, Christophe, Zaidi, Manel, Coulouvrat, Sandra, Col, Edwige, Chanez, Pascal, Greillier, Laurent, Tomasini, Pascale, Barlesi, Fabrice, Mascaux, Céline, Jourdan, Sandrine, Roger, Aurélie, Biemar, Julie, Randriamampionona, Rondro, Chabot, François, Tiotiu, Angélica, Clement-Duchene, Christelle, Vignaud, Jean-Michel, Lacomme, Stéphanie, Lomazzi, Sandra, Laurent, Carine, Bulsei, Xavier, Bischoff, Laura, Rakotonirina, Raymond, Layouni, Mehdi, Deslee, Gaëtan, Mal, Hervé, Kessler, Romain, Vergnon, Jean-Michel, Pelissier, Isabelle, Cuvelier, Antoine, Bourdin, Arnaud, Jounieaux, Vincent, Roche, Nicolas, Jouneau, Stéphane, Bonniaud, Philippe, Scherpereel, Arnaud, Mornex, Jean François, Steenhouwer, François, Leroy, Sylvie, Marquette, Charles Hugo, Benzaquen, Jonathan, Mazzette, Andrea, Padovani, Bernard, Hofman, Paul, Ilié, Marius, Hofman, Véronique, Fayada, Julien, Long-Mira, Elodie, Lassalle, Sandra, Pradelli, Johanna, Martinez, Estelle, Habault, Marine, Bonnard, Mélanie, Moutarde, Julie, Yatimi, Rachida, Labsi, Hakima, Gazoppi, Loïc, Lpce, Tumorothèque, Griffonnet, Jennifer, Fontaine, Maureen, Guillemart, Ariane, Butori, Catherine, Selva, Eric, Poudenx, Michel, Otto, Josiane, Hebert, Christophe, Botchiellini, Delphine, Boudouf, Soukaina, Menier, Margaux, Occeli, Estelle, Bellentani, Sophie, Pion, Carine, Fournier, Elodie, Thariat, Juliette, Gervais, Radj, Hamond, Karim, Marchand-Adam, Sylvain, Plantier, Laurent, Fajolle, Gaelle, Rayez, Mélanie, Cadranel, Jacques, Fallet, Vincent, Wislez, Marie, Antoine, Martine, Cote, Jean-François, Chaabane, Nouha, Ruppert, Anne Marie, Bertrand, Eliane, Rodenas, Anita, Pontdeme, Gwenaëlle, Mathiot, Nathalie, Ribert, Tamazouzt, Mazières, Julien, Guibert, Nicolas, Rouviere, Damien, Bousquet, Emilie, Bigay-Game, Laurence, Hermant, Christophe, Plat, Gavin, Rouquette, Isabelle, Evrard, Solène, Gouin, Sandrine, Clermont, Estelle Taranchon, Dormoy, Inge, Coulomb, Christelle, Pradine, Anne, Lambert, Véronique, Laborde, Lilian, Castelnau, Olivier, Chamorey, Emmanuel, Heeke, Simon, Thamphya, Brice, Boutros, Jacques, Clément-Duchêne, Christelle, Marquette, Charles-Hugo

Source: In Journal of Thoracic Oncology May 2021 16(5):807-816

Lung cancer survivors and employment: A systematic review

Authors: Vayr, Flora, Savall, Frédéric, Bigay-Game, Laurence, Soulat, Jean-Marc, Chouaid, Christos, Herin, Fabrice

Source: In Lung Cancer May 2019 131:31-39

Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients

Alternate Title: Incidence des effets indésirables thyroïdiens chez les patients ayant un cancer bronchique non à petites cellules au cours d’un traitement par nivolumab (French)

Authors: Campredon, Pauline, Mouly, Céline, Lusque, Amélie, Bigay-Game, Laurence, Bousquet, Emilie, Mazières, Julien, Caron, Philippe

Source: In La Presse Médicale April 2019 48(4):e199-e207

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non–Small-cell Lung Cancer: A Phase I Study

Authors: Massabeau, Carole, Khalifa, Jonathan, Filleron, Thomas, Modesto, Anouchka, Bigay-Gamé, Laurence, Plat, Gavin, Dierickx, Lawrence, Aziza, Richard, Rouquette, Isabelle, Gomez-Roca, Carlos, Mounier, Muriel, Delord, Jean-Pierre, Toulas, Christine, Olivier, Pascale, Chatelut, Etienne, Mazières, Julien, Cohen-Jonathan Moyal, Elizabeth

Source: In Clinical Lung Cancer May 2018 19(3):e277-e285

Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit

Authors: Puisset, Florent, Bigay-Game, Laurence, Paludetto, Marie Noëlle, Martel, Audrey, Perriat, Sophie, Rabeau, Audrey, Canonge, Jean Marie, Mazieres, Julien

Source: Supportive care in cancer. 27(5):1679-1686

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125295748.0x000001&indx=1&recIds=ETOCvdc_100125295748.0x000001

Three-Year Overall Survival of Patients With Advanced Non–Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).

Authors: Decroisette, Chantal, Greillier, Laurent, Curcio, Hubert, Pérol, Maurice, Ricordel, Charles, Auliac, Jean-Bernard, Falchero, Lionel, Veillon, Remi, Vieillot, Sabine, Guisier, Florian, Marcq, Marie, Justeau, Grégoire, Bigay-Game, Laurence, Bernardi, Marie, Doubre, Hélène, Pinsolle, Julian, Amrane, Karim, Chouaïd, Christos, Descourt, Renaud

Source: Journal of Immunotherapy; Jan2024, Vol. 47 Issue 1, p16-20, 5p

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Authors: Chour, Ali, Denis, Julie, Mascaux, Céline, Zysman, Maeva, Bigay-Game, Laurence, Swalduz, Aurélie, Gounant, Valérie, Cortot, Alexis, Darrason, Marie, Fallet, Vincent, Auclin, Edouard, Basse, Clémence, Tissot, Claire, Decroisette, Chantal, Bombaron, Pierre, Giroux-Leprieur, Etienne, Odier, Luc, Brosseau, Solenn, Creusot, Quentin, Gueçamburu, Marina, Meersseman, Corentin, Rochand, Adrien, Costantini, Adrien, Gaillard, Claire Marine, Wasielewski, Eric, Girard, Nicolas, Cadranel, Jacques, Lafitte, Claire, Lebossé, Fanny, Duruisseaux, Michaël

Source: In Journal of Thoracic Oncology October 2023 18(10):1408-1415

Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.

Authors: Doubre, Hélène, Greillier, Laurent, Justeau, Grégoire, Ricordel, Charles, Swalduz, Aurélie, Curcio, Hubert, Bylicki, Olivier, Auliac, Jean-Bernard, Guisier, Florian, Bigay-Game, Laurence, Bernardi, Marie, Pinsolle, Julian, Amrane, Karim, Decroisette, Chantal, Descourt, Renaud, Chouaid, Christos, Geier, Margaux

Source: Journal of Cancer Research & Clinical Oncology; Nov2023, Vol. 149 Issue 16, p15095-15102, 8p

Subject Terms: NON-small-cell lung carcinoma, PROGRAMMED death-ligand 1, PEMBROLIZUMAB

Geographic Terms: FRANCE

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial)

Authors: Westeel, Virginie, Quoix, Elisabeth, Puyraveau, Marc, Lavolé, A., Braun, Denis, Laporte, Silvy, Bigay-Game, Laurence, Pujol, Jean-Louis, Ozenne, Gervais, Rivière, Alain, Douillard, Jean-Yves, Lebeau, Bernard, Debieuvre, Didier, Poudenx, Michel, David, Philippe, Molinier, Olivier, Zalcman, Gérard, Lemarié, Etienne, Morin, Franck, Depierre, Alain, Milleron, Bernard

Source: In European Journal of Cancer August 2013 49(12):2654-2664

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Authors: Quoix, Elisabeth, Zalcman, Gérard, Oster, Jean-Philippe, Westeel, Virginie, Pichon, Eric, Lavolé, Armelle, Dauba, Jérôme, Debieuvre, Didier, Souquet, Pierre-Jean, Bigay-Game, Laurence, Dansin, Eric, Poudenx, Michel, Molinier, Olivier, Vaylet, Fabien, Moro-Sibilot, Denis, Herman, Dominique, Bennouna, Jaafar, Tredaniel, Jean, Ducoloné, Alain, Lebitasy, Marie-Paule, Baudrin, Laurence, Laporte, Silvy, Milleron, Bernard

Source: In The Lancet 2011 378(9796):1079-1088

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).

Authors: Descourt, Renaud, Greillier, Laurent, Perol, Maurice, Ricordel, Charles, Auliac, Jean-Bernard, Falchero, Lionel, Gervais, Radj, Veillon, Rémi, Vieillot, Sabine, Guisier, Florian, Marcq, Marie, Justeau, Grégoire, Bigay-Game, Laurence, Bernardi, Marie, Fournel, Pierre, Doubre, Hélène, Pinsolle, Julian, Amrane, Karim, Chouaïd, Christos, Decroisette, Chantal

Source: Cancer Immunology, Immunotherapy; Jan2023, Vol. 72 Issue 1, p91-99, 9p

Subject Terms: NON-small-cell lung carcinoma, BRAIN metastasis, PEMBROLIZUMAB, NEUTROPHIL lymphocyte ratio, PROGRESSION-free survival

Geographic Terms: FRANCE

Impact of Induction Treatment on Postoperative Complications in the Treatment of Non-small Cell Lung Cancer

Authors: Brouchet, Laurent, Bauvin, Eric, Marcheix, Bertrand, Bigay-Game, Laurence, Renaud, Claire, Berjaud, Jean, Falcoze, Pierre Emmanuel, Venissac, Nicolas, Raz, Dan, Jablons, David, Mazières, Julien, Dahan, Marcel

Source: In Journal of Thoracic Oncology July 2007 2(7):626-631

First-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric cohort—ESCKEYP trial (GFPC 05-2018).

Authors: Descourt, Renaud, Greillier, Laurent, Perol, Maurice, Ricordel, Charles, Auliac, Jean-Bernard, Falchero, Lionel, Demontrond, Pierre, Veillon, Remi, Vieillot, Sabine, Guisier, Florian, Marcq, Marie, Justeau, Gregoire, Bigay Game, Laurence, Bernardi, Marie, Fournel, Pierre, Doubre, Helene, Pinsolle, Julian, Amrane, Karim, Chouaid, Christos, Decroisette, Chantal

Source: Journal of clinical oncology. 39(15 suppl):9091-9091

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173220133.0x000001&indx=1&recIds=ETOCvdc_100173220133.0x000001

Outcomes of thymic epithelial tumors (TETs) with pleural metastases: Real-world insight from RYTHMIC.

Authors: Maury, Jean-Michel, Benitez, Jose Carlos, Boucher, Marie Eve, Dansin, Eric, Kerjouan, Mallorie, Bigay-Game, Laurence, Pichon, Eric, Thillays, Francois, Falcoz, Pierre-Emmanuel, Svetlana, Lyubimova, Oulkhouir, Youssef, Fabien, Calcagno, Thiberville, Luc, Clément Duchene, Christelle, Westeel, Virginie, Missy, Pascale, Thomas, Pascal Alexandre, Molina, Thierry, Girard, Nicolas, Besse, Benjamin

Source: Journal of clinical oncology. 39(15 suppl):8578-8578

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173218379.0x000001&indx=1&recIds=ETOCvdc_100173218379.0x000001

This result is not displayed to guests.
Login for full access.

Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit.

Authors: Puisset, Florent^1,2,3 Puisset.florent@iuct-oncopole.fr, Bigay-Game, Laurence⁴, Paludetto, Marie Noëlle^1,2 paludetto.marienoelle@iuct-oncopole.fr, Martel, Audrey¹ Martel.Audrey@iuct-oncopole.fr, Perriat, Sophie⁵ Perriat.Sophie@iuct-oncopole.fr, Rabeau, Audrey⁴ rabeau.a@chu-toulouse.fr, Canonge, Jean Marie⁵ Canonge.Jean-Marie@iuct-oncopole.fr, Mazieres, Julien^4,6 mazieres.j@chu-toulouse.fr

Source: Supportive Care in Cancer. May2019, Vol. 27 Issue 5, p1679-1686. 8p.

Subject Terms: *LUNG cancer, *HYDRATION, *GLOMERULAR filtration rate, *KIDNEY disease prevention, *TREATMENT of lung tumors, *ANTINEOPLASTIC agents, *CISPLATIN, *FLUID therapy, *INTRAVENOUS therapy, *KIDNEY diseases, *LONGITUDINAL method, *LUNG tumors, *DISEASE incidence, *RETROSPECTIVE studies